BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three studies of its novel BCL2 inhibitor, Mesutoclax (ICP-248), were presented at the 67th Annual Meeting of the American Society of Hematology (ASH). Mesutoclax demonstrated remarkable…
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A (ticker: WESFX), Class C (ticker: WEFCX), and/or Class I (ticker: WEIFX) shares of the Wildermuth Fund between November 1, 2020 and June 29, 2023, both dates inclusive (the “Class Period”), of the…
RADNOR, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. (“CarMax”) (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20,…
Chicago, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The global contract intelligence market was valued at US$ 1,113.59 million in 2024 and is projected to surpass market valuation of US$ 7,212.65 million by 2033 at a CAGR of 23.07% during the forecast period 2025–2033.
Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capital Partners, today announced that the Science Based Targets initiative (SBTi) has validated the company’s near-term greenhouse gas (GHG) emissions reduction targets. This approval marks an important milestone…
